ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

May 27, 2005

RFA On Breast Tumor Factors Patients Survival

June 20, 1980

Leyland-Jones Named Director of Emory’s Winship Cancer Institute

November 17, 2006

President to Propose 2 Percent Increase in NIH Budge, Slowing Funding Growth

January 15, 1999

Cancer Survivorship: NCI, Komen, OWH Fund Research Grants

December 5, 1997